A Silicon Valley law firm is launching a Boston office, headed by three IP attorneys who have left the local branch of ...

A Silicon Valley law firm is launching a Boston office, headed by three IP attorneys who have left the local branch of ...

Alumis Inc., a clinical-stage biopharmaceutical company developing therapies using a precision approach to optimize clinical outcomes and significantly improve the lives of patients with ...

Morgan Stanley & Co. LLC and Cooley LLP are advising Alumis, while Guggenheim Securities, LLC, Fenwick & West LLP, and Paul Hastings LLP are advising ACELYRIN. This announcement is based on a ...

Guggenheim Securities, LLC is serving as financial advisor to ACELYRIN and Fenwick & West LLP and Paul Hastings LLP are serving as legal counsel. ACELYRIN, INC. (Nasdaq: SLRN) is focused on ...

Guggenheim Securities, LLC is serving as financial advisor to ACELYRIN and Fenwick & West LLP and Paul Hastings LLP are serving as legal counsel. Alumis is a clinical-stage biopharmaceutical ...

Guggenheim Securities, LLC is serving as financial advisor to ACELYRIN and Fenwick & West LLP and Paul Hastings LLP are serving as legal counsel. This communication contains forward-looking ...

Guggenheim Securities, LLC is serving as financial advisor to ACELYRIN and Fenwick & West LLP and Paul Hastings LLP are serving as legal counsel. ACELYRIN, INC. (Nasdaq: SLRN) is focused on ...